Clinical significance of cardiac troponins I and T in acute heart failure.
BACKGROUND
Elevated cardiac troponin (cTn) levels are relatively common in acute heart failure (AHF).


OBJECTIVE
To evaluate the prevalence and prognostic significance of elevated cTnI and cTnT in AHF.


METHODS
FINN-AKVA is a prospective, multicenter study in AHF. In this analysis, 364 non-ACS patients with measurements of cTnI and cTnT taken on admission and 48 h thereafter were analyzed.


RESULTS
Of the 364 AHF patients, 51.1% had cTnI and 29.7% cTnT levels above the cut-off value. Six-month all-cause mortality was 18.7%. Both cTnI (OR 2.0, 95% CI 1.2-3.5, p=0.01) and cTnT (OR 2.6, 95% CI 1.5-4.4, p=0.0006) were associated with adverse outcome. The mortality risk was proportional to the magnitude of cTn release. On multivariable analysis, Cystatin C (OR 6.3, 95% CI 3.2-13, p<0.0001), logNT-proBNP (OR 1.4, 95% CI 1.0-1.8, p=0.03) and systolic blood pressure on admission (/10 mm Hg increase, OR 0.9, 95% CI 0.8-0.9, p=0.0004) were independent risk markers, whereas the troponins were not significantly associated with increased mortality.


CONCLUSIONS
cTn elevations are frequent in AHF patients without ACS. cTnI is more often elevated than cTnT. Both cTnI and cTnT elevations are associated with increased mortality proportional to the degree elevation but they do not act as independent risk markers.
Ilva
Tuomo
T
Department of Internal Medicine, Kanta-Hame Central Hospital, Finland. tuomo.ilva@pp.inet.fi
Lassus
Johan
J
Siirilä-Waris
Krista
K
Melin
John
J
Peuhkurinen
Keijo
K
Pulkki
Kari
K
Nieminen
Markku S
MS
Mustonen
Harri
H
Porela
Pekka
P
Harjola
Veli-Pekka
VP
D000368:Aged; D001794:Blood Pressure; D005260:Female; D006333:Heart Failure / Q000378:metabolism*; D006801:Humans; D008297:Male; D009206:Myocardium / Q000737:chemistry*; D011379:Prognosis; D011446:Prospective Studies; D019210:Troponin I / Q000032:analysis*; D020107:Troponin T / Q000032:analysis*
D019210:Troponin I; D020107:Troponin T